The Successful Use of Desmopressin With Tranexamic Acid in Children With Mild Type 1 Von Willebrand Disease Who Undergo Circumcision

Hayri Elicabuk, Halil Beydilli, Mehmet Akin, Mustafa Serinken

Abstract


Background: Desmopressin (DDAVP) is a synthetic vasopressin analog, and increases endogenous von Willebrand factor (VWF) by secreting it from the vascular endothelial cell. Circumcision is one of the oldest and most commonly performed operations in the world. This study reported the specific uses of DDAVP together with tranexamic acid in children with mild type 1 von Willebrand disease (VWD) undergoing circumcision. The aim of this study was to report the successful use of DDAVP in two doses and tranexamic acid in six children with VWD undergoing circumcision.

Methods: Our study evaluated two doses of DDAVP therapy in circumcision operation of six male children diagnosed with mild type 1 VWD with a good response to DDAVP before they underwent circumcision, with a mean age of 7.3 years. The subcutaneous preparation of DDAVP was utilized. Under medical supervision, patients were subcutaneously injected DDAVP at a dose between 0.3 and 0.2 μg/kg based on their weight. Oral tranexamic acid was instituted at a dosage of 15 mg/kg three times per day for 5 days. The first dose was given 24 hours before circumcision. The first and second doses of DDAVP were given 1 hour before the circumcision and 24 hours after the circumcision, respectively.

Results: This study included six male children aged 4 - 10 years with mild type 1 VWD, weighting 22 - 30 kg. The DDAVP dose (mean, range) based on the patient’s weight was 0.25 (0.23 - 0.28 μg/kg). The calculated dose was repeated two times for each patient. Laboratory values (mean, range, U/dL) of baseline VWF:Ag, VWF:RCo and FVIII:C in mild type 1 VWD patients were 37 (32 - 42), 38 (34 - 42), and 50 (44 - 56), respectively.

Conclusion: Single infusions of DDAVP for common bleeding episodes do not usually require laboratory monitoring. There are limited published data to guide clinical practice about the optimal dosing and timing of these agents to prevent or resolve bleeding using DDAVP at minor surgeries as circumcision operation. Castaman et al showed almost all minor surgeries and deliveries occurring during follow-up were successfully managed with DDAVP in patients with type 1 VWD. We used two doses in circumcision like O’Brein. Comparison of the results across studies is difficult, as surgical techniques, timing, and frequency of DDAVP dosing, and use and dosing of antifibrinolytics all varied by institution. Two doses of DDAVP allowed adequate perioperative bleeding prophylaxis management in children with mild type 1 VWD who underwent circumcision surgery with presenting bleeding complications.




Int J Clin Pediatr. 2015;4(4):181-183
doi: http://dx.doi.org/10.14740/ijcp228e


Keywords


VWD; Desmopressin; Circumcision

Full Text: HTML PDF
 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

International Journal of Clinical Pediatrics, quarterly, ISSN 1927-1255 (print), 1927-1263 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International
CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (
ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (
COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.theijcp.org   editorial contact: editor@theijcp.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.